Psoriasis Arthritis
11
6
6
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
27%
3 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (11)
Psoriasis Comorbidities at Hospital Calderón Guardia
Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease
A Study of Clinical and Immune Responses to Sequential Biologic Therapies in Psoriatic Arthritis
GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis
A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers
Molecular Inflammation Board at the Center for Personalized Medicine
Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Paris Saint-Joseph Hospital Group"
A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)
Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)
Prospective Evaluation of the Radiographic Efficacy of Enbrel